Guildford, UK – Royal Philips (NYSE: PHG; AEX: PHIA) has today announced the UK launch of the DreamMapper app and website, designed to assist people living with sleep apnoea to improve treatment adherence by providing tools and real time tracking and analysis of their positive airway pressure (PAP) therapy. DreamMapper works as part of the Philips Dream Family portfolio which includes DreamStation, a sleep therapy system, and DreamWear, a minimal contact nasal mask. This system uses patient-designed therapy devices and the latest in data mobilisation technology to help people best manage their sleep apnoea.
DreamMapper is now available in the UK for Android and Apple smartphones, tablets and desktop systems and quickly correlates and analyses data on therapy usage, mask fit and apnoea hypopnea index (AHI) readings to help improve treatment success as well as helping users set and achieve personal therapy goals. In addition to providing continuous therapy analysis, the platform also provides troubleshooting support, conveniently supplying users with instructional videos that address a variety of potential therapy challenges. In turn this has the potential to reduce NHS clinician contact time, freeing up hours away from more administrative therapy enquiries.
Karen Danville from Hull was one of the first people to benefit from DreamMapper in the UK, stating; “I check DreamMapper every morning as I wake up to see how much therapy time I have had and how good my mask fit was. It also has some helpful information about sleep apnoea. I would highly recommend this app to all my fellow sleep apnoea sufferers. I love it.”
Working as part of the Dream Family suite, clinicians also see the benefits as DreamMapper connects and monitors the patient’s use of DreamStation, an important part of PAP delivery and adherence, as Hannah Hunt, respiratory physiologist at Llandough Hospital in Wales explains: “Patients like that it (DreamStation) isn’t an obvious medical device at first glance, while it’s one of the simplest devices we have come across for both patients and us. Accessing the clinical menu is simple, and patients are able to look at as much or as little data as they require. The Three Night Summary that pops up in the morning is a great feature as it gives them a quick guide to how they are complying with treatment. We look forward to being able to enhance our patients’ experience further with DreamMapper.”
To help enhance the patient experience, DreamMapper also provides motivation enhancement therapy coaching tools to inspire users and encourage adherence. Bernadette Coleman from Philips remarks, “We’re very excited about the potential of DreamMapper to enable people living with sleep apnoea to take control of their own care by supporting them with technology that’s integrated into their therapy. Global statistics have shown that DreamMapper can improve sleep therapy adherence by 22% and we look forward to seeing similar benefits in the UK.”
For more information on DreamMapper or any of the Dream Family range, please visit: https://www.philips.co.uk/healthcare/consumer/sleep-apnea/living-with-sleep-apnoea/dream-family
Twitter: @PhilipsUK – #DreamMapper
 ‘SystemOne retrospective study’, Philips Respironics, 2015